Chemoinformaics analysis of FURAN, 3-METHYL-2-(3-METHYL-2-BUTENYL)-
| Molecular Weight | 150.221 | nRot | 2 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 6 |
| Exact Molecular Weight | 150.104 | nRing | 1 |
| Solubility: LogS | -3.665 | nHRing | 1 |
| Solubility: LogP | 3.832 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 5 |
| nHA | 1 | APOL | 26.8371 |
| nHD | 0 | BPOL | 15.7809 |
| QED | 0.59 |
| Synth | 2.854 |
| Natural Product Likeliness | 1.925 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.009 |
| HIA | 0.004 |
| CACO-2 | -4.459 |
| MDCK | 0.0000292 |
| BBB | 0.214 |
| PPB | 0.947953 |
| VDSS | 3.914 |
| FU | 0.0839647 |
| CYP1A2-inh | 0.966 |
| CYP1A2-sub | 0.584 |
| CYP2c19-inh | 0.848 |
| CYP2c19-sub | 0.599 |
| CYP2c9-inh | 0.438 |
| CYP2c9-sub | 0.704 |
| CYP2d6-inh | 0.087 |
| CYP2d6-sub | 0.669 |
| CYP3a4-inh | 0.12 |
| CYP3a4-sub | 0.281 |
| CL | 16.204 |
| T12 | 0.547 |
| hERG | 0.027 |
| Ames | 0.024 |
| ROA | 0.048 |
| SkinSen | 0.142 |
| Carcinogencity | 0.372 |
| EI | 0.858 |
| Respiratory | 0.399 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.906219 |